BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18626428)

  • 21. Assessment of the capability of a gelling complex made of tara gum and the exopolysaccharides produced by the microorganism Streptococcus thermophilus ST10 to prospectively restore the gut physiological barrier: a pilot study.
    Del Piano M; Balzarini M; Carmagnola S; Pagliarulo M; Tari R; Nicola S; Deidda F; Pane M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S56-61. PubMed ID: 25291130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial flora as a cause or treatment of chronic diarrhea.
    Scaldaferri F; Pizzoferrato M; Pecere S; Forte F; Gasbarrini A
    Gastroenterol Clin North Am; 2012 Sep; 41(3):581-602. PubMed ID: 22917165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influences of enteral nutrition combined with probiotics on gut microflora and barrier function of rats with abdominal infection.
    Shen TY; Qin HL; Gao ZG; Fan XB; Hang XM; Jiang YQ
    World J Gastroenterol; 2006 Jul; 12(27):4352-8. PubMed ID: 16865777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics and liver disease.
    Sheth AA; Garcia-Tsao G
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S80-4. PubMed ID: 18542037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of thermal injury on intestinal bacterial translocation and the mitigating role of probiotics: A review of animal and human studies.
    Knackstedt R; Gatherwright J
    Burns; 2020 Aug; 46(5):1005-1012. PubMed ID: 31351819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
    Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
    World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What we gained from a century of investigations of symbiontic intestinal microflora].
    Ter Arkh; 2012; 84(2):5-10. PubMed ID: 22715654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intestinal flora and bacterial infection in cirrhosis.
    Riordan SM; Williams R
    J Hepatol; 2006 Nov; 45(5):744-57. PubMed ID: 16979776
    [No Abstract]   [Full Text] [Related]  

  • 29. New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in paediatric age.
    Cucchiara S; Falconieri P; Di Nardo G; Parcelii MA; Dito L; Grandinetti A
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S44-7. PubMed ID: 12408439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites.
    Pérez-Paramo M; Muñoz J; Albillos A; Freile I; Portero F; Santos M; Ortiz-Berrocal J
    Hepatology; 2000 Jan; 31(1):43-8. PubMed ID: 10613726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?
    Blum S; Schiffrin EJ
    Curr Issues Intest Microbiol; 2003 Sep; 4(2):53-60. PubMed ID: 14503689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis.
    Moratalla A; Gómez-Hurtado I; Moya-Pérez Á; Zapater P; Peiró G; González-Navajas JM; Gómez Del Pulgar EM; Such J; Sanz Y; Francés R
    Eur J Nutr; 2016 Feb; 55(1):197-206. PubMed ID: 25657013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel prevention strategies for bacterial infections in cirrhosis.
    Yan K; Garcia-Tsao G
    Expert Opin Pharmacother; 2016; 17(5):689-701. PubMed ID: 26799197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Establishment of the intestinal microflora in neonates].
    Campeotto F; Waligora-Dupriet AJ; Doucet-Populaire F; Kalach N; Dupont C; Butel MJ
    Gastroenterol Clin Biol; 2007 May; 31(5):533-42. PubMed ID: 17541346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotic agents in the treatment of irritable bowel syndrome.
    Guslandi M
    J Int Med Res; 2007; 35(5):583-9. PubMed ID: 17900396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics: which and when?
    Scarpellini E; Cazzato A; Lauritano C; Gabrielli M; Lupascu A; Gerardino L; Abenavoli L; Petruzzellis C; Gasbarrini G; Gasbarrini A
    Dig Dis; 2008; 26(2):175-82. PubMed ID: 18431068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases.
    Plaza-Díaz J; Ruiz-Ojeda FJ; Gil-Campos M; Gil A
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
    Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U
    World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.